Ferozsons Laboratories Limited (PSX:FEROZ)

Ferozsons Laboratories Balance Sheet

Financials in millions PKR. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Cash & Equivalents	505.62	551.06	569.05	415.83	830.51	151.39
Short-Term Investments	250.38	-	-	-	-	-
Trading Asset Securities	4,553	496.5	544.97	2,036	1,940	760.71
Cash & Short-Term Investments	5,309	1,048	1,114	2,452	2,771	912.1
Cash Growth	296.06%	-5.96%	-54.57%	-11.51%	203.81%	-19.48%
Accounts Receivable	2,880	2,417	1,123	1,140	1,540	1,093
Other Receivables	275.84	283.81	259.9	432.11	23.37	39.27
Receivables	3,156	2,700	1,383	1,572	1,563	1,132
Inventory	5,955	4,978	5,196	3,260	2,107	2,116
Prepaid Expenses	-	11.84	7.05	1.15	0.42	0.92
Other Current Assets	1,010	1,046	833	468.26	629.81	716.87
Total Current Assets	15,430	9,783	8,533	7,754	7,071	4,877
Property, Plant & Equipment	11,846	11,828	7,975	6,113	4,792	3,996
Other Intangible Assets	37.12	41.04	1.55	1	0.64	0.42
Other Long-Term Assets	97.12	96.98	93.92	93.92	93.92	93.71
Total Assets	27,410	21,750	16,603	13,962	11,958	8,967
Accounts Payable	3,906	1,125	2,716	1,657	1,354	998.52
Accrued Expenses	143.58	897.6	539.82	611.89	615.99	371.47
Short-Term Debt	4,761	2,743	1,261	492.52	-	51.02
Current Portion of Long-Term Debt	383.18	333.07	379.88	141.69	181.53	28.32
Current Unearned Revenue	397.42	471.27	251.96	200.95	79.89	34.72
Other Current Liabilities	100.72	514.79	343.17	282.76	287.6	309.02
Total Current Liabilities	9,692	6,085	5,491	3,387	2,519	1,793
Long-Term Debt	1,842	1,844	1,841	1,537	957.1	95.07
Long-Term Unearned Revenue	415.47	476.91	531.88	331.33	174.13	4.68
Long-Term Deferred Tax Liabilities	1,497	1,524	375.36	408.64	415.23	426.23
Total Liabilities	13,447	9,929	8,240	5,664	4,066	2,319
Common Stock	434.69	434.69	434.69	362.24	362.24	301.87
Retained Earnings	7,887	7,040	6,290	6,100	5,713	4,645
Comprehensive Income & Other	3,649	3,754	1,193	1,305	1,398	1,474
Total Common Equity	11,970	11,228	7,918	7,768	7,473	6,421
Minority Interest	1,993	591.88	445.45	530.68	419.17	227.89
Shareholders' Equity	13,964	11,820	8,364	8,298	7,892	6,648
Total Liabilities & Equity	27,410	21,750	16,603	13,962	11,958	8,967
Total Debt	6,986	4,920	3,482	2,171	1,139	174.41
Net Cash (Debt)	-1,677	-3,872	-2,368	280.9	1,632	737.7
Net Cash Growth	-	-	-	-82.79%	121.28%	-33.70%
Net Cash Per Share	-38.57	-89.08	-54.47	6.46	37.55	16.97
Filing Date Shares Outstanding	43.47	43.47	43.47	43.47	43.47	43.47
Total Common Shares Outstanding	43.47	43.47	43.47	43.47	43.47	43.47
Working Capital	5,737	3,698	3,042	4,367	4,552	3,084
Book Value Per Share	275.37	258.31	182.16	178.70	171.92	147.70
Tangible Book Value	11,933	11,187	7,917	7,767	7,473	6,420
Tangible Book Value Per Share	274.52	257.36	182.12	178.67	171.91	147.69
Land	-	1,691	849.15	849.15	849.15	849.15
Buildings	-	2,013	1,117	1,048	1,028	1,014
Machinery	-	5,077	3,363	2,980	2,660	2,470
Construction In Progress	297.66	3,708	4,160	2,337	1,011	97.46

Source: S&P Global Market Intelligence. Standard template. Financial Sources.